受β1肾上腺素能受体信号调控的调节性黏膜相关恒定T细胞促进肝细胞癌进展
该研究结合单细胞RNA测序与流式细胞术,在肝细胞癌患者中发现FOXP3+CXCR3+黏膜相关恒定T细胞为具有高免疫抑制潜力的调节性MAIT细胞(MAITreg),其由FOXP3-CXCR3+MAIT细胞诱导而来,β1肾上腺素能受体信号分别促进其诱导与功能;瘤内MAITreg比例高与不良临床结局相关。
要点
- 肝细胞癌患者中FOXP3+CXCR3+MAIT细胞为调节性MAIT细胞(MAITreg),具高免疫抑制潜力。
- MAITreg主要由FOXP3-CXCR3+MAIT细胞在Treg诱导条件下诱导产生。
- β1肾上腺素能受体信号促进MAITreg的诱导与功能,瘤内MAITreg比例高与不良临床结局相关。
核心结论
- 研究揭示了肝细胞癌患者中一种免疫抑制性MAIT细胞亚群MAITreg,其促进肝细胞癌进展,并提出通过神经免疫串扰进行控制的思路。
研究设计与样本
- 研究采用单细胞RNA测序(scRNA-seq)联合流式细胞术,对肝细胞癌患者样本进行表型与功能研究。
主要发现
- 肝细胞癌患者中FOXP3+CXCR3+MAIT细胞为调节性MAIT细胞(MAITreg),具有高免疫抑制潜力。
- MAITreg在Treg诱导条件下被诱导,主要来源于FOXP3-CXCR3+MAIT细胞,该细胞群表现出轻度Treg相关特征,代表前MAITreg储库。
- β1肾上腺素能受体信号在前MAITreg中促进MAITreg的诱导,在MAITreg中促进其功能。
- 肝细胞癌患者中瘤内MAITreg高比例抑制抗肿瘤免疫应答,并与不良临床结局相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The innate-like mucosa-associated invariant T (MAIT) cells are enriched in human liver and have been linked to human HCC. However, their contributions to the progression of HCC are controversial due to the heterogeneity of MAIT cells, and new MAIT cell subsets remain to be explored. APPROACH AND RESULTS: Combining single cell RNA sequencing (scRNA-seq) and flow cytometry analysis, we performed phenotypic and functional studies and found that FOXP3 + CXCR3 + MAIT cells in HCC patients were regulatory MAIT cells (MAITregs) with high immunosuppressive potential. These MAITregs were induced under Treg-inducing condition and predominantly from FOXP3 - CXCR3 + MAIT cells, which displayed mild Treg-related features and represented a pre-MAITreg reservoir. In addition, the induction and function of MAITregs were promoted by β1 adrenergic receptor signaling in pre-MAITregs and MAITregs, respectively. In HCC patients, high proportion of the intratumoral MAITregs inhibited antitumor immune responses and was associated with poor clinical outcomes. CONCLUSIONS: Together, we reveal an immunosuppressive subset of MAIT cells in HCC patients that contributes to HCC progression, and propose a control through neuroimmune crosstalk.
引用
- Fu S, Liu M, Zhu C, et al. Regulatory mucosa-associated invariant T cells controlled by β1 adrenergic receptor signaling contribute to hepatocellular carcinoma progression. Hepatology. 2023. PMID: 36626624. doi:10.1097/HEP.0000000000000014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。